Skip to main
We’re doing some system maintenance
  1. Home
  2. Stocks
  3. Black Diamond Therapeutics
BDTX

Buy BDTX Stock

BDTX
See BDTX stock price and Buy/Sell Black Diamond Therapeutics with any amount of money. Discuss news and analyst's price prediction with the investor community. Enter your cell phone number to get started.
BDTX

Black Diamond Therapeutics (BDTX)

About Black Diamond Therapeutics (BDTX)

Black Diamond Therapeutics, Inc. is a precision oncology medicine company, which engages in discovery and development of small molecule, masterkey therapies. The company was founded by David M. Epstein and Elizabeth Buck in 2014 and is headquartered in Cambridge, MA.
Market Cap
$62.06M
1 Year High
$14.18
Volume
122.63k
1 Year Low
$1.65
Price to Earnings Ratio
Open
$1.80
Dividend Rate
High
$1.83
Dividend Yield
Low
$1.66

Community

People who own or watch BDTX stock

BDTX Stock News

BDTX stock rating

What analysts recommend for BDTX stock, on a scale from 1 (buy) to 5 (sell).
Buy
Sell
1.9

BDTX price target

What analysts think BDTX will be worth
Low $1.65
High $14.18
Current $1.71
Target $8

Events

List of events that could affect BDTX stock.
11May

Earnings data Q1 2022

11Aug

Earnings data Q2 2022

BDTX earnings

The value each share was expected to gain vs. the value that each share actually gained
0
-0.32
-0.65
-0.97
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022

Expected EPS
Q2 2022
-$0.72
Actual EPS
Q2 2022

Buy BDTX Stock

BDTX
See BDTX stock price and Buy/Sell Black Diamond Therapeutics with any amount of money. Discuss news and analyst's price prediction with the investor community. Enter your cell phone number to get started.

Community

People who own or watch BDTX stock
  • karma777 avatar
  • Tysori55 avatar
  • marifritz avatar
  • Oxfordmeme avatar
  • jtoom723 avatar
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings Inc. (“Public Holdings”). This is not an offer, solicitation of an offer or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Cryptocurrency trading is provided by Apex Crypto LLC (“Apex Crypto”). Apex Crypto is not a registered broker-dealer or FINRA member and is not affiliated with Public Holdings or any of its subsidiaries. Cryptocurrencies are not securities and your cryptocurrency holdings are not FDIC or SIPC insured. Crypto trading involves a substantial risk of loss as there is significant volatility in the price of cryptocurrencies.

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S. listed securities electronically. Keep in mind, that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.